Pilanci, K. N. Et Al. 2015. Is Administration of Trastuzumab an Independent Risk Factor for Developing Osteonecrosis of the Jaw Among Metastatic Breast Cancer Patients Under Zoledronic Acid Treatment?. MEDICINE , vol.94, no.18 .

Pilanci, K. N., Alco, G., Ordu, C., Sarsenov, D., Celebi, F., Erdogan, Z., ... Agacayak, F.(2015). Is Administration of Trastuzumab an Independent Risk Factor for Developing Osteonecrosis of the Jaw Among Metastatic Breast Cancer Patients Under Zoledronic Acid Treatment?. MEDICINE , vol.94, no.18.

Pilanci, Kezban Et Al. "Is Administration of Trastuzumab an Independent Risk Factor for Developing Osteonecrosis of the Jaw Among Metastatic Breast Cancer Patients Under Zoledronic Acid Treatment?," MEDICINE , vol.94, no.18, 2015

Pilanci, Kezban N. Et Al. "Is Administration of Trastuzumab an Independent Risk Factor for Developing Osteonecrosis of the Jaw Among Metastatic Breast Cancer Patients Under Zoledronic Acid Treatment?." MEDICINE , vol.94, no.18, 2015

Pilanci, K. N. Et Al. (2015) . "Is Administration of Trastuzumab an Independent Risk Factor for Developing Osteonecrosis of the Jaw Among Metastatic Breast Cancer Patients Under Zoledronic Acid Treatment?." MEDICINE , vol.94, no.18.

@article{article, author={Kezban Nur Pilanci Et Al. }, title={Is Administration of Trastuzumab an Independent Risk Factor for Developing Osteonecrosis of the Jaw Among Metastatic Breast Cancer Patients Under Zoledronic Acid Treatment?}, journal={MEDICINE}, year=2015}